GSK S DRUG

UK authorises GSK's drug to treat endometrial cancer

Jemperli is now authorised to be used together with chemotherapy to slow the progression of endometrial cancers, increasing life expectancy for patients, the UK's Medicines and Healthcare products Regulatory Agency said.